What is Abel Screening?
Abel Screening operates within the healthcare technology sector, providing specialized services that include appointment-based telephone consultations with expert clinicians. The company emphasizes its support for new customers, encouraging them to leverage these consultations to better interpret ASI test reports, a service offered at no additional charge. Furthermore, Abel Screening extends technical support via telephone and email from Monday to Friday, 8 a.m. to 7 p.m. Eastern Time, also without extra cost. This commitment to client support and data interpretation services positions Abel Screening as a key player in facilitating accurate diagnostic insights.
How much funding has Abel Screening raised?
Abel Screening has raised a total of $126K across 1 funding round:
Debt
$126K
Debt (2021): $126K with participation from PPP
Key Investors in Abel Screening
PPP
Public-Private Partnership
What's next for Abel Screening?
The substantial debt financing of $126 million, classified as a major strategic investment, signals Abel Screening's readiness for significant expansion or operational enhancement. As a company in a large-scale late-stage funding phase, this capital injection is likely earmarked for accelerating market penetration, enhancing its proprietary ASI testing technology, or expanding its network of expert clinicians. The strategic nature of this backing suggests a focus on long-term growth and solidifying its market position within the competitive healthcare diagnostics landscape. Future developments may include broader service offerings or strategic partnerships to further leverage its diagnostic capabilities.
See full Abel Screening company page
